A V Karaulov Selected Research

A V Karaulov Research Topics

Disease

6	COVID-19 02/2023 - 12/2020
4	Infections 05/2021 - 10/2009
3	Neoplasms (Cancer) 04/2021 - 05/2015
2	Hypersensitivity (Allergy) 10/2023 - 04/2019
2	Inflammation (Inflammations) 10/2022 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2022 - 01/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 12/2020
2	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2016
1	Anaphylaxis (Anaphylactic Shock) 10/2023
1	Atopic Dermatitis (Atopic Eczema) 09/2023
1	Asthma (Bronchial Asthma) 09/2023
1	Rhinosinusitis 09/2023
1	Coronavirus Infections 02/2023
1	Disease Progression 06/2022
1	Human Influenza (Influenza) 10/2021
1	Virus Diseases (Viral Diseases) 10/2021
1	Pneumonia (Pneumonitis) 10/2021
1	Experimental Melanoma 04/2021
1	Hyperplasia 11/2019
1	Herpes Simplex 07/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 04/2016
1	Brain Ischemia (Cerebral Ischemia) 01/2016
1	Cross Infection (Nosocomial Infection) 01/2016
1	Hyperglycemia 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2015
1	Spontaneous Abortion (Miscarriage) 05/2015
1	Myocardial Infarction 03/2015
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Immune System Diseases (Immune Disorders) 01/2013
1	Dysbiosis 01/2013
1	Pancreatitis 06/2011
1	Shock 01/2010
1	Chronic Bronchitis 01/2010

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 10/2022 - 01/2017
3	Monoclonal AntibodiesIBA 09/2023 - 05/2015
3	Messenger RNA (mRNA)IBA 01/2017 - 03/2015
2	Interleukin-4 (Interleukin 4)IBA 09/2023 - 10/2022
2	AntibodiesIBA 10/2022 - 05/2021
2	Immunoglobulin G (IgG)IBA 10/2022 - 05/2021
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2017
2	Immunoglobulin M (IgM)IBA 10/2022 - 05/2021
2	AntigensIBA 05/2021 - 06/2011
2	glucosaminylmuramyl- 2- alanine- D- isoglutamineIBA 01/2021 - 12/2020
2	Acetylmuramyl-Alanyl-IsoglutamineIBA 05/2015 - 10/2009
1	AllergensIBA 10/2023
1	Interleukin-13IBA 09/2023
1	dupilumabIBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	InterleukinsIBA 09/2023
1	tixagevimabIBA 02/2023
1	4-O-carboxymethylascochlorinIBA 02/2023
1	cilgavimabIBA 02/2023
1	Interleukin-8 (Interleukin 8)IBA 10/2022
1	regdanvimabIBA 06/2022
1	Tilorone (Tilorone Hydrochloride)IBA 10/2021
1	InterferonsIBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021
1	Bacterial LysatesIBA 01/2021
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2021
1	BCG Vaccine FDA Link 12/2020
1	VaccinesIBA 12/2020
1	Peptidoglycan (Murein)IBA 12/2020
1	ChromiumIBA 11/2019
1	Potassium Dichromate FDA Link 11/2019
1	LatexIBA 04/2019
1	Antiviral Agents (Antivirals)IBA 07/2017
1	MucinsIBA 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2016
1	Prednisolone (Predate)FDA LinkGeneric 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Differentiation AntigensIBA 01/2016
1	CholesterolIBA 01/2016
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2016
1	Nonesterified Fatty Acids (NEFA)IBA 01/2016
1	LipidsIBA 01/2016
1	Membrane LipidsIBA 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2016
1	EnzymesIBA 05/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 03/2015
1	NLR ProteinsIBA 01/2013
1	HLA-DR Antigens (HLA-DR)IBA 06/2011
1	Immunoglobulin E (IgE)IBA 01/2010
1	GlycosidesIBA 10/2009

Therapy/Procedure

3	Therapeutics 09/2023 - 03/2015
1	Respiratory Therapy (Therapy, Respiratory) 06/2022
1	Aftercare (After-Treatment) 01/2016
1	Immunotherapy 01/2013